17 April 2013

Edinburgh, Scotland

The Scottish Government is bringing together a range of experts, including the police, health experts and community organisations to discuss how the problem of legal highs in Scotland can be tackled.

25 - 28 August 2013

Brisbane, Australia

This study focuses on synthetic cannabinoids, the epidemiological background on the latest new drugs in Europe or the presence of these new drugs in drivers.

3 September 2013

Glasgow, UK

The conference, organised jointly by Scottish Drugs Forum and Crew, will focus on the new trends of drug use in Scotland and feature the launch of the findings from three studies.

6 November 2013 09:45-16:30

London, UK

This conference will focus on the latest developments in drug use and their impact on services.

12 - 13 September 2013

Swansea, United Kingdom

This conference will present the latest scientific research in this ever changing world and will aim to highlight the dangers these drugs represent.

15 October 2013 09:00-17:00

Melbourne, Autralia

The National Drug Trends Conference will present recent findings in illicit drug use, markets and related harms across Australia and internationally.

15 - 16 May 2014

Rome, Italy

This conference aims to increase knowledge on the NPS and promote innovative solutions on the risks associated to them.

1 May 2014 09:30-17:00

London, UK

This is the first in a series of conferences exploring the future of NPS regulation.

29 October 2014

Glasgow, Scotland

There will be 25 discussion groups, workshops and presentations, 36 exhibition stands and poster presentations.

14 November 2014

Liverpool, UK

The first five speakers have been confirmed for the conference: Dr. Carl Hart, Prof. Alex Stevens, Dr. Magdelena Harris, Anne-Marie Cockburn, Prof. Gerry Stimson and David Stuart.

30 April 2015

Glasgow, Scotland

This conference will discuss the adequate planning and delivery of drug services in Scotland.

25 June 2015

Northampton, East Midlands, England

This conference will discuss the increasing use of New Psychoactive Substances and will provide speakers and delegates with an opportunity to learn from each other’s experiences as well as hearing about the latest national perspectives.

5 - 6 October 2015

Guadalajara, Mexico

This congress focuses on the traditional and contemporary use of drugs in indigenous, mestizo, and urban communities in Mexico and Brazil. Informal and cultural means of control, and their relationship with formal and legal controls, will also be explored.

23 - 25 November 2015

Lisbon, Portugal

The aim of the course is to recall current trends and developments in European NPS markets, discuss current policies and identify barriers and problems in developing effective harm reduction responses targeting people who use drugs heavily in Europe.

28 October 2015

Brussels, Belgium

This International Symposium provides a timely opportunity for practitioners and stakeholders across Europe to discuss the latest challenges and consider the next steps needed to win the fight against illicit drug trafficking and substance misuse through holistic, multi-level and cross-border approaches.

28 - 29 October 2015

Lisbon, Portugal

This EMCDDA meeting brings together European health professionals and researchers to explore the challenges, needs and best practice around responding to NPS in a variety of health and intervention settings

27 June - 8 July 2016

Lisbon, Portugal

Two-week summer school in Lisbon on the drugs problem in Europe and beyond involving Scientific Experts from the EMCDDA and guest lecturers from European Universities.

15 March 2016 09:00-16:00

London, United Kingdom

Unique opportunity to discuss New Psychoactive Substances (NPS) issues across the UK and the potential impact of future legislation.

2 - 4 October 2016

Venice, Italy

The Global Addiction Association is a knowledge-sharing facility for all those involved in the understanding and treatment of addiction.

11 - 12 May 2016

Auckland, New Zealand

This conference will explore innovative regulatory responses to new psychoactive substances and cannabis, which are in the middle ground between absolute prohibition and unregulated commercial markets.